Teva Atty Says Gilead Deal Followed Bad News On FDA Filing

By Bonnie Eslinger · June 7, 2023, 10:32 PM EDT

A top Teva lawyer testified Wednesday in an antitrust trial over claims that the company struck an illegal "pay for delay" deal with Gilead over two HIV medications, saying Teva reached...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Case Information

Case Title

In re HIV Antitrust Litigation

Case Number

3:19-cv-02573

Court

California Northern

Nature of Suit

Anti-Trust

Date Filed

May 14, 2019